What is the Intercritical Period of Gout
The intercritical period of gout is the asymptomatic, pain-free interval between acute gout flares during which patients have no joint symptoms, yet monosodium urate (MSU) crystals remain present in the joint and continue to deposit silently. 1, 2
Clinical Characteristics
The intercritical period represents a deceptive phase of gout where:
- Patients are completely asymptomatic with no pain, swelling, or joint tenderness 3, 4
- MSU crystals persist in affected joints despite the absence of symptoms 5, 6
- Crystal deposition continues silently during this seemingly inactive phase 4, 5
- Duration is highly variable, ranging from days to years between attacks 4, 7
Natural History and Progression
Early Disease Pattern
In the initial stages of gout, intercritical periods tend to be:
- Prolonged, lasting months to years between flares 3
- Brief acute episodes (3-5 days) separated by these long asymptomatic intervals 3
Disease Progression
As gout advances without adequate treatment:
- Intercritical periods shorten progressively 3, 4
- Flares become more frequent and prolonged (≥5-10 days) 3
- Eventually evolves into chronic gouty arthritis with minimal to no pain-free intervals 3, 4
- Tophi develop and joint damage occurs 3, 4
Critical Diagnostic Implications
MSU crystals can be identified during the intercritical period, making diagnosis possible even when the joint is asymptomatic [@1-9@, 6]:
- Sensitivity of 70% for detecting crystals during intercritical periods (compared to 84% during acute attacks) 8
- Specificity of 95% when crystals are found 8
- Arthrocentesis of asymptomatic joints is feasible: In one study, synovial fluid was successfully obtained from 91 of 101 asymptomatic joints 6
Important Caveat
Urate-lowering therapy affects crystal detection: Among patients receiving hypouricemic agents, only 71% (34/48) had detectable crystals in intercritical synovial fluid, compared to 100% (43/43) of those not on treatment 6. This means a negative aspirate during the intercritical period in treated patients does not exclude gout.
Clinical Significance
The intercritical period is not a benign phase—it represents ongoing disease activity with:
- Continued MSU crystal accumulation 4, 5
- Progressive joint damage risk 3
- Opportunity for definitive diagnosis via joint aspiration 6
- Critical window for initiating urate-lowering therapy to prevent progression 3
The presence of asymptomatic intervals should not delay treatment initiation, as the disease is actively progressing even when patients feel well 3, 5.